Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_assertion type Assertion NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_head.
- NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_assertion wasGeneratedBy ECO_0000203 NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_provenance.
- NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_assertion wasDerivedFrom befree-20140225 NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_provenance.
- NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_assertion SIO_000772 23053881 NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_provenance.
- NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_assertion evidence source_evidence_literature NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_provenance.
- NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_assertion description "[In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_provenance.